Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antirheumatic Agents"" wg kryterium: Temat


Tytuł:
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.
Autorzy:
Fasano S; Rheumatology Unit, Department of Precision Medicine, University of Campania, 'Luigi Vanvitelli', Naples, Italy .
Messiniti V; Rheumatology Unit, Department of Precision Medicine, University of Campania, 'Luigi Vanvitelli', Naples, Italy.
Iudici M; Department of Internal Medicine Specialties, Geneva University Hospitals, Geneva, Switzerland.
Coscia MA; Rheumatology Unit, Department of Precision Medicine, University of Campania, 'Luigi Vanvitelli', Naples, Italy.
Ciccia F; Rheumatology Unit, Department of Precision Medicine, University of Campania, 'Luigi Vanvitelli', Naples, Italy.
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2023 Jan; Vol. 10 (1).
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Antirheumatic Agents*/adverse effects
Retinal Diseases*/chemically induced
Humans ; Hydroxychloroquine/adverse effects ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Tytuł:
Enhanced Anti-Inflammatory Effect of the Combination of Lactiplantibacillus plantarum LS/07 with Methotrexate Compared to Their Monotherapies Studied in Experimental Arthritis.
Autorzy:
Pružinská K; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.; Jessenius Faculty of Medicine in Martin, Comenius University, Malá Hora 4A, 03601 Martin, Slovakia.
Slovák L; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Dráfi F; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Poništ S; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Juránek I; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Chrastina M; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.; Jessenius Faculty of Medicine in Martin, Comenius University, Malá Hora 4A, 03601 Martin, Slovakia.
Švík K; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Strojný L; Center of Clinical and Preclinical Research, Faculty of Medicine, Pavol Jozef Šafárik University, Trieda SNP 1, 04011 Košice, Slovakia.
Ambro Ľ; Center for Interdisciplinary Biosciences, Technology and Innovation Park, Pavol Jozef Šafárik University, Jesenná 5, 04001 Košice, Slovakia.
Bauerová K; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Dec 30; Vol. 28 (1). Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Experimental*/drug therapy
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Rats ; Animals ; Methotrexate/pharmacology ; Methotrexate/therapeutic use ; Drug Therapy, Combination ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Tytuł:
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review.
Autorzy:
Peretti S; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Torracchi S; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Russo E; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Bonomi F; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Fiorentini E; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Aoufy KE; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Bruni C; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.; Department of Rheumatology, University Hospital of Zurich, University of Zurich, 8006 Zurich, Switzerland.
Lepri G; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Orlandi M; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Chimenti MS; Rheumatology, Allergology and Clinical Immunology, Department of Medicina dei Sistemi, University of Rome Tor Vergata, 00133 Rome, Italy.
Guiducci S; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Amedei A; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Matucci-Cerinic M; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, 20132 Milan, Italy.
Bellando Randone S; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Pokaż więcej
Źródło:
Genes [Genes (Basel)] 2022 Dec 28; Vol. 14 (1). Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Janus Kinase Inhibitors*/therapeutic use
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Humans ; Methotrexate/pharmacology ; Methotrexate/therapeutic use ; Abatacept/therapeutic use ; Rituximab/therapeutic use ; Interleukin-17 ; Yin-Yang ; Interleukin-12/therapeutic use
Czasopismo naukowe
Tytuł:
The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry.
Autorzy:
Padula AS; Northern California Arthritis Center, 120 La Casa Via, Suite 204, Walnut Creek, CA, 94598, USA. .
Pappas DA; CorEvitas, Waltham, MA, USA.
Fiore S; Sanofi, Bridgewater, NJ, USA.
Blachley TS; CorEvitas, Waltham, MA, USA.
Ford K; Sanofi, Bridgewater, NJ, USA.
Emeanuru K; CorEvitas, Waltham, MA, USA.; Evidera, Bethesda, MD, USA.
Kremer JM; CorEvitas, Waltham, MA, USA.
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2022 Dec 21; Vol. 24 (1), pp. 276. Date of Electronic Publication: 2022 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia*/chemically induced
Antirheumatic Agents*/adverse effects
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Inflammation*/chemically induced
Adult ; Female ; Humans ; Male ; Hemoglobins/chemistry ; Registries ; Tumor Necrosis Factor Inhibitors/adverse effects ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Tumor Necrosis Factor-alpha ; Receptors, Interleukin-6/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
Autorzy:
Kihara M; Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan. .; Pharmaceuticals and Medical Devices Agency, Office of Pharmacovigilance II, Tokyo, Japan. .
Sugihara T; Graduate School of Medical and Dental Science, Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Asano J; Pharmaceuticals and Medical Devices Agency, Office of New Drug IV, Tokyo, Japan.; Graduate School of Medical and Dental Sciences, Department of Clinical Biostatistics, Tokyo Medical and Dental University, Tokyo, Japan.
Sato M; Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan.
Kaneko H; Division of Rheumatic Disease, National Centre for Global Health and Medicine, Tokyo, Japan.
Muraoka S; Department of Internal Medicine, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Tokyo, Japan.
Ohshima S; Department of Clinical Research, National Hospital Organization Osaka Minami Medical Centre, Kawachinagano, Japan.
Nanki T; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Clinical rheumatology [Clin Rheumatol] 2022 Dec; Vol. 41 (12), pp. 3661-3673. Date of Electronic Publication: 2022 Aug 16.
Typ publikacji:
Multicenter Study; Observational Study; Journal Article
MeSH Terms:
COVID-19*/epidemiology
Rheumatology*
Antirheumatic Agents*/therapeutic use
Rheumatic Diseases*/complications
Rheumatic Diseases*/epidemiology
Rheumatic Diseases*/drug therapy
Diabetes Mellitus*/epidemiology
Physicians*
Adult ; Humans ; SARS-CoV-2 ; Japan/epidemiology ; COVID-19 Testing ; Registries ; Oxygen ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Tytuł:
Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis: a nationwide nested case-control study.
Autorzy:
Dieperink SS; Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark .; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Mehnert F; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Nørgaard M; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Oestergaard LB; Cardiovascular Research Center, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.
Benfield T; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
Petersen A; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Torp-Pedersen C; Department of Cardiology, Copenhagen University Hospital - North Zealand, Hillerød, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Glintborg B; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Center for Arthritis Research (COPECARE) and the DANBIO Registry, Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
Hetland ML; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Center for Arthritis Research (COPECARE) and the DANBIO Registry, Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
Pokaż więcej
Źródło:
RMD open [RMD Open] 2022 Dec; Vol. 8 (2).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacteremia*/drug therapy
Bacteremia*/epidemiology
Bacteremia*/etiology
Staphylococcal Infections*/drug therapy
Staphylococcal Infections*/epidemiology
Staphylococcal Infections*/chemically induced
Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/epidemiology
Humans ; Female ; Aged ; Male ; Case-Control Studies ; Staphylococcus aureus ; Glucocorticoids/adverse effects
Czasopismo naukowe
Tytuł:
Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.
Autorzy:
Wang J; Immunology Systems Computational Biology, Genomic Research Center, AbbVie, Cambridge, Massachusetts.
Conlon D; Immunology Discovery, AbbVie Research Center, Worcester, Massachusetts.
Rivellese F; Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Nerviani A; Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Lewis MJ; Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Housley W; Immunology Discovery, AbbVie Research Center, Worcester, Massachusetts.
Levesque MC; Immunology Discovery, Cambridge Research Center, Cambridge, Massachusetts.
Cao X; Immunology Systems Computational Biology, Genomic Research Center, AbbVie, Cambridge, Massachusetts.
Cuff C; Immunology Discovery, AbbVie Research Center, Worcester, Massachusetts.
Long A; Immunology Discovery, AbbVie Research Center, Worcester, Massachusetts.
Pitzalis C; Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ruzek MC; Immunology Discovery, AbbVie Research Center, Worcester, Massachusetts.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2022 Dec; Vol. 74 (12), pp. 1916-1927. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Antirheumatic Agents*/metabolism
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/genetics
Humans ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Synovial Membrane/metabolism ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł:
Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review.
Autorzy:
Wientjes MHM; Rheumatology, Sint Maartenskliniek, Ubbergen, The Netherlands .; Radboud Institute for Health Sciences, Radboudumc, Nijmegen, The Netherlands.
den Broeder AA; Rheumatology, Sint Maartenskliniek, Ubbergen, The Netherlands.; Rheumatology, Radboudumc, Nijmegen, The Netherlands.
Welsing PMJ; Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Verhoef LM; Rheumatology, Sint Maartenskliniek, Ubbergen, The Netherlands.
van den Bemt BJF; Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands.; Pharmacy, Radboudumc, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
RMD open [RMD Open] 2022 Dec; Vol. 8 (2).
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/genetics
Humans ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Rheumatoid Factor ; Autoantibodies ; Biomarkers
Czasopismo naukowe
Tytuł:
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study.
Autorzy:
Tidblad L; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden .
Westerlind H; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Delcoigne B; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Askling J; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Saevarsdottir S; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
RMD open [RMD Open] 2022 Dec; Vol. 8 (2).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/epidemiology
Arthritis, Rheumatoid*/chemically induced
Antirheumatic Agents*
Renal Insufficiency, Chronic*/chemically induced
Renal Insufficiency, Chronic*/drug therapy
Humans ; Sweden/epidemiology ; Methotrexate/therapeutic use ; Comorbidity
Czasopismo naukowe
Tytuł:
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance.
Autorzy:
Simons G; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Janssen EM; Janssen Research and Development, Titusville, New Jersey, USA.
Veldwijk J; Erasmus School of Health Policy and Management and Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
DiSantostefano RL; Janssen Research and Development, Titusville, New Jersey, USA.
Englbrecht M; Freelance Data Scientist, Eckental, Germany.
Radawski C; Eli Lilly and Company, Indianapolis, Indiana, USA.
Valor-Méndez L; Department of Internal Medicine and Institute for Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum, Erlangen, Germany.
Humphreys JH; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Kellgren Centre for Rheumatology, Manchester University NHS Foundation Trust, Manchester, UK.
Bruce IN; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Kellgren Centre for Rheumatology, Manchester University NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Hauber B; Pfizer, New York, New York, USA.
Raza K; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; Department of Rheumatology, Sandwell and West Birmingham NHS Trust, Birmingham, UK.; Research into Inflammatory Arthritis Centre Versus Arthritis and MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, UK.
Falahee M; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK .
Pokaż więcej
Źródło:
RMD open [RMD Open] 2022 Dec; Vol. 8 (2).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthritis, Rheumatoid*/epidemiology
Arthritis, Rheumatoid*/etiology
Arthritis, Rheumatoid*/prevention & control
Antirheumatic Agents*/therapeutic use
Adult ; Humans ; Male ; Middle Aged ; Aged ; Demography
Czasopismo naukowe
Tytuł:
Mesenchymal stromal cell therapy for patients with rheumatoid arthritis.
Autorzy:
Harna B; Department of Orthopaedics, Maulana Azad Medical College, New Delhi, 110002, India; Indian Stem Cell Study Group (ISCSG) Association, Lucknow, 226010, Uttar Pradesh, India; Fellow in Orthopaedic Rheumatology, Dr. RML National Law University, Lucknow, 226010, Uttar Pradesh, India.
Kalra P; Department of Orthopaedics, Maulana Azad Medical College, New Delhi, 110002, India.
Arya S; Department of Radiodiagnosis, Maulana Azad Medical College, New Delhi, 110002, India.
Jeyaraman N; Indian Stem Cell Study Group (ISCSG) Association, Lucknow, 226010, Uttar Pradesh, India; Fellow in Orthopaedic Rheumatology, Dr. RML National Law University, Lucknow, 226010, Uttar Pradesh, India; Fellow in Regenerative Interventional Orthobiologics, Dr. RML National Law University, Lucknow, 226010, Uttar Pradesh, India; Department of Orthopaedics, Rathimed Specialty Hospital, Chennai, 600040, Tamil Nadu, India.
Nallakumarasamy A; Indian Stem Cell Study Group (ISCSG) Association, Lucknow, 226010, Uttar Pradesh, India; Fellow in Orthopaedic Rheumatology, Dr. RML National Law University, Lucknow, 226010, Uttar Pradesh, India; Fellow in Regenerative Interventional Orthobiologics, Dr. RML National Law University, Lucknow, 226010, Uttar Pradesh, India; Department of Orthopaedics, All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India.
Jeyaraman M; Indian Stem Cell Study Group (ISCSG) Association, Lucknow, 226010, Uttar Pradesh, India; Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, 600056, Tamil Nadu, India; Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, 201310, Uttar Pradesh, India; South Texas Orthopaedic Research Institute (STORI Inc.), Laredo, TX, 78045, USA. Electronic address: .
Rajendran RL; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 41944, South Korea.
Oh EJ; Department of Plastic and Reconstructive Surgery, CMRI, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 41944, South Korea.
Khanna M; Indian Stem Cell Study Group (ISCSG) Association, Lucknow, 226010, Uttar Pradesh, India.
Rajendran UM; ICMR-Vector Control Research Centre, Puducherry, 605006, India.
Chung HY; Department of Plastic and Reconstructive Surgery, CMRI, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 41944, South Korea.
Ahn BC; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 41944, South Korea; BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu, 41944, South Korea. Electronic address: .
Gangadaran P; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, 41944, South Korea; BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu, 41944, South Korea. Electronic address: .
Pokaż więcej
Źródło:
Experimental cell research [Exp Cell Res] 2023 Feb 01; Vol. 423 (1), pp. 113468. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Arthritis, Rheumatoid*/therapy
Antirheumatic Agents*/therapeutic use
Mesenchymal Stem Cells*
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*/methods
Humans
Czasopismo naukowe
Tytuł:
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.
Autorzy:
Schneeberger EE; Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina. Electronic address: .
Citera G; Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina.
Nash P; Department of Medicine, Griffith University, Brisbane, Queensland, Australia.
Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, United States.
Soriano ER; Rheumatology Unit, Hospital Italiano de Buenos Aires and Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Helling C; Pfizer Inc, Buenos Aires, Argentina.
Szumski AE; Pfizer Inc, Collegeville, PA, United States.
Mundayat R; Pfizer Inc, New York, NY, United States.
de León DP; Pfizer Inc, Lima, Peru.
Pokaż więcej
Źródło:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Feb; Vol. 58, pp. 152134. Date of Electronic Publication: 2022 Nov 13.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Psoriatic*/diagnostic imaging
Arthritis, Psoriatic*/drug therapy
Humans ; Piperidines/therapeutic use ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation.
Autorzy:
Lauro W; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Picone V; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Abategiovanni L; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Vastarella M; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Gallo L; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Fabbrocini G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Megna M; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Pokaż więcej
Źródło:
International journal of dermatology [Int J Dermatol] 2023 Feb; Vol. 62 (2), pp. e70-e72. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Arthritis, Psoriatic*/drug therapy
Antirheumatic Agents*/therapeutic use
Humans ; Certolizumab Pegol/adverse effects ; Alopecia/chemically induced ; Alopecia/diagnosis ; Alopecia/drug therapy ; Polyethylene Glycols/therapeutic use ; Treatment Outcome
Raport
Tytuł:
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C).
Autorzy:
Singh N; Division of Rheumatology, Department of Internal Medicine, University of Washington, Seattle, WA 98195, United States.
Madhira V; Palila Software, Reno, NV, United States.
Hu C; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States.
Olex AL; Virginia Commonwealth University, Wright Center for Clinical and Translational Research, 203 E Cary St, Richmond, VA 23298, United States.
Bergquist T; Sage Bionetworks, Seattle, WA 98109, United States.
Fitzgerald KC; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States.
Huling JD; Division of Biostatistics, University of Minnesota, Minneapolis, MN, United States.
Patel RC; Departments of Medicine and Global Health, University of Washington, Seattle, WA, 98104, United States.
Singh JA; Medicine Service, VA Medical Center, 700 19th St S, Birmingham, AL 35233 United States; Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), 510 20th Street S, Birmingham, AL 35294-0022, United States; Department of Epidemiology at the UAB School of Public Health, 1665 University Blvd., Ryals Public Health Building, Birmingham, AL 35294-0022, United States. Electronic address: .
Pokaż więcej
Źródło:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Feb; Vol. 58, pp. 152149. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
COVID-19*
Arthritis, Rheumatoid*/complications
Antirheumatic Agents*/adverse effects
Humans ; Female ; Middle Aged ; Aged ; Rituximab/adverse effects ; Retrospective Studies ; Cohort Studies ; Pandemics ; COVID-19 Testing
Czasopismo naukowe
Tytuł:
Downregulation of pro-inflammatory markers IL-6 and TNF-α in rheumatoid arthritis using nano-lipidic carriers of a quinone-based phenolic: an in vitro and in vivo study.
Autorzy:
Pal RR; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Rajpal V; Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Singh N; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Singh S; Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Uttar Pradesh, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow, 226001, India.
Mishra N; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Singh P; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Maurya P; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Alka; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India.
Saraf SA; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University Lucknow (A Central University), Uttar Pradesh, VidyaVihar, Raebareli Road, Lucknow, 226 025, India. .
Pokaż więcej
Źródło:
Drug delivery and translational research [Drug Deliv Transl Res] 2023 Feb; Vol. 13 (2), pp. 627-641. Date of Electronic Publication: 2022 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Antirheumatic Agents*
Arthritis, Rheumatoid*/drug therapy
Anti-Inflammatory Agents/pharmacology ; Down-Regulation ; Drug Carriers/chemistry ; Interleukin-6 ; Quinones/therapeutic use ; Tumor Necrosis Factor-alpha/metabolism ; Animals
Czasopismo naukowe
Tytuł:
A retrospective claims analysis confirms the cost of most biologic agents for psoriasis is increasing more rapidly than medical inflation.
Autorzy:
Patel D; Department of Dermatology, the Mount Sinai Hospital, New York, New York. Electronic address: .
Svoboda R; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Maczuga S; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Foulke GT; Department of Dermatology, the University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Helm M; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Feb; Vol. 88 (2), pp. 490-493. Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:
Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Biological Products*/therapeutic use
Psoriasis*/drug therapy
Dermatologic Agents*/therapeutic use
Humans ; Retrospective Studies ; Biological Factors/therapeutic use ; Insurance Claim Review
Czasopismo naukowe
Tytuł:
A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.
Autorzy:
Park JK; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, and Seoul National University Hospital, Seoul, Republic of Korea.
Lee YJ; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea, and Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Shin K; Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kang EH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Ha YJ; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Park JW; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim MJ; Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kim MH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Choi SR; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Jung Y; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lee JH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
In Jung J; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim JY; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Winthrop KL; Division of Infectious Diseases, Oregon Health and Science University, Portland.
Lee EB; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea, and Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Feb; Vol. 75 (2), pp. 171-177. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/administration & dosage
Influenza, Human*/prevention & control
Influenza, Human*/chemically induced
Influenza, Human*/drug therapy
Humans ; Influenza A Virus, H3N2 Subtype ; Methotrexate/therapeutic use ; Prospective Studies ; Seasons ; Vaccination
Czasopismo naukowe
Tytuł:
Systematic review on the use of biologics in adult-onset still's disease.
Autorzy:
Fautrel B; Sorbonne Université, INSERM UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, Département de Rhumatologie, F75013 Paris, France.
Patterson J; York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK.
Bowe C; York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK. Electronic address: .
Arber M; York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK.
Glanville J; York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK.
Mealing S; York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK.
Canon-Garcia V; Novartis Pharma, Basel, Switzerland.
Fagerhed L; Novartis Pharma, Basel, Switzerland.
Rabijns H; Novartis Pharma, Basel, Switzerland.
Giacomelli R; Clinical Unit of Rheumatology and Clinical Immunology, University of Rome 'Campus Biomedico', School of Medicine, 00128 Rome, Italy.
Pokaż więcej
Źródło:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Feb; Vol. 58, pp. 152139. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Still's Disease, Adult-Onset*/drug therapy
Antirheumatic Agents*/therapeutic use
Biological Products*/therapeutic use
Adult ; Humans ; Biological Factors/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Predictors of response of rituximab in rheumatoid arthritis by weighted gene co-expression network analysis.
Autorzy:
Zhang S; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Li P; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Wu P; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Yang L; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Liu X; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Liu J; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Zhang Y; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China.
Zeng J; Rheumatology and Immunology Department, Affiliated Hospital of Guizhou Medical University, Yunyan District, 28 Guiyi Street, Guiyang, 550004, Guizhou, China. .
Pokaż więcej
Źródło:
Clinical rheumatology [Clin Rheumatol] 2023 Feb; Vol. 42 (2), pp. 529-538. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/genetics
Humans ; Rituximab/therapeutic use ; Gene Expression Profiling ; Biomarkers ; Gene Regulatory Networks
Czasopismo naukowe
Tytuł:
Cachexia measured by bioelectrical impedance vector analysis and risk of infection in women with rheumatoid arthritis.
Autorzy:
Ogata-Medel M; Clinical Nutrition Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Mexico City, 14080, Mexico.; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
Llorente L; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Hinojosa-Azaola A; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Lozada-Mellado M; Clinical Nutrition Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Mexico City, 14080, Mexico.
Pineda-Juarez JA; Research Coordination, Centro Médico Nacional 20 de Noviembre, ISSSTE, Mexico City, Mexico.
Rocha-Gonzalez HI; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
Castillo-Martinez L; Clinical Nutrition Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Mexico City, 14080, Mexico. .
Pokaż więcej
Źródło:
Clinical rheumatology [Clin Rheumatol] 2023 Feb; Vol. 42 (2), pp. 391-397. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
Female ; Humans ; Body Composition ; Cachexia/epidemiology ; Cachexia/etiology ; Electric Impedance ; Methotrexate/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz